ST7-AS1: A Potential Drug Target and Biomarker (G93653)

Target Name: ST7-AS1

NCBI ID: G93653

ST7-AS1

Other Name(s): ST7 antisense RNA 1 | ST7OT1 | ST7AS1

ST7-AS1: A Potential Drug Target and Biomarker

Introduction

Stem cells are a crucial cell type that have the ability to develop into any type of cell in the body. They are found in various tissues and organs and have the potential to regenerate damaged tissue and organs. However, stem cells have a limited lifespan and are often resistant to drugs. This has led to a need for new treatments and biomarkers to help identify and treat stem cell disorders.

One potential drug target and biomarker for stem cells is ST7-AS1, a small non-coding RNA molecule. ST7-AS1 has been identified as a potential drug target due to its unique structure and its role in the development and maintenance of stem cells.

Structure of ST7-AS1

ST7-AS1 is a non-coding RNA molecule that was identified by RNA-seq analysis of human tissues. It has a length of 242 nucleotides and a 29 base pair repeat at its 5' end. The molecule has a single exon at its 3 ' end, which is located between positions 184 and 187 nucleotides.

Function of ST7-AS1

ST7-AS1 is involved in the development and maintenance of stem cells. It has been shown to be expressed in various tissues and organs, including the brain, heart, and liver. It has also been shown to be involved in the regulation of stem cells proliferation and differentiation.

One of the most significant functions of ST7-AS1 is its role in the regulation of stem cell self-renewal. Stem cells are capable of self-renewing and have the potential to differentiate into any type of cell in the body. ST7-AS1 has has been shown to be involved in the regulation of stem cell self-renewal by promoting the expression of genes that promote cell proliferation and survival.

Another function of ST7-AS1 is its role in the regulation of stem cell differentiation. Stem cells have the potential to differentiate into any type of cell in the body, and ST7-AS1 has been shown to be involved in the regulation of this process. It has been shown to promote the expression of genes that promote stem cell differentiation and the transition to a different cell type.

Drug Targeting

ST7-AS1 has been identified as a potential drug target due to its unique structure and its role in the development and maintenance of stem cells. Drugs that target ST7-AS1 have the potential to treat a variety of stem cell disorders, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the potential mechanisms by which ST7-AS1 could be targeted is its role in the regulation of stem cell self-renewal. Drugs that inhibit the expression of genes that promote stem cell self-renewal could potentially be effective in treating stem cell disorders.

Another potential mechanism by which ST7-AS1 could be targeted is its role in the regulation of stem cell differentiation. Drugs that inhibit the expression of genes that promote stem cell differentiation could potentially be effective in treating stem cell disorders.

Biomarker

ST7-AS1 has also been identified as a potential biomarker for stem cell disorders. Its unique structure and function make it an attractive candidate for use as a biomarker.

Conclusion

ST7-AS1 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker for stem cells. Its unique structure and function make it an attractive candidate for use in the treatment of stem cell disorders. Further research is needed to fully understand the role of ST7-AS1 in the development and maintenance of stem cells and its potential as a drug target and biomarker.

Protein Name: ST7 Antisense RNA 1

The "ST7-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ST7-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets